02 - 04 October, 2024
CNIT, Paris
Mirexa Capital was created to better service clients
in constantly evolving markets – both in terms of regulatory changes and as
traditional market participants change the way that they operate. The
company’s team has experience operating in various trading, sales and research
roles in a wide range of financial institutions.
The company provides liquidity in all major cash and
derivative asset classes, focusing on the foreign exchange, credit, and
interest rate markets. Its global institutional clients include hedge funds,
asset managers, central banks and private banks. The company is active in
over-the-counter (OTC) and exchange-listed products. Mirexa Capital benefits
from TrueQuote and CrossTrade, multi asset electronic solutions for the buy
side.
Mirexa Capital is part of TP ICAP group which manages
a portfolio of businesses, providing intermediary services, contextual insights
and intelligence, trade execution solutions, and data and analytics. For
further information on TP ICAP please visit www.tpicap.com.